风湿性关节炎与反信号识别粒子相关的免疫媒介性结性肌痛病:一个病例报告
Mohamed Reda Belkhribchia1, Johannes Alexander Lobrinus2, Lamyaa Semlil1
1Hassan II Regional Hospital, Dakhla, Morocco.
Journal of investigative medicine high impact case reports
|February 14, 2024
概括
与类风湿性关节炎相关的免疫媒介性死性肌肉病变 (IMNM) 是罕见的. 一名患有抗SRPIMNM和RA的患者在修复药和环胺治疗后显著改善.
科学领域:
- 类风湿病学 类风湿病学
- 神经学 神经学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫媒介性死性肌肉病 (IMNM) 是一种罕见的异常性炎症性肌肉病.
- 它表现为严重的肌肉衰弱,亡和肌酸激酶的升高.
- 在许多IMNM病例中发现了抗信号识别粒子 (anti-SRP) 和抗HMGCR自身抗体.
研究的目的:
- 报告一个年轻女性患有类风湿性关节炎 (RA) 和严重抗SRP IMNM的不寻常病例.
- 突出IMNM与结缔组织疾病之间的潜在关联.
- 描述Rituximab和Cyclophosphamide联合治疗方案的治疗结果.
主要方法:
- 一个年轻女子被诊断患有类风湿性关节炎和抗SRP的案例报告IMNM.
- 治疗包括Rituximab和Cyclophosphamide.
- 监测临床反应和副作用.
主要成果:
- 该患者出现了严重的亚急性靠近肌肉衰弱和肌酸激酶的升高.
- 诊断证实为抗SRP阳性的IMNM.
- 结合利图西马布和环胺的治疗方案导致了显著的临床改善.
- 在治疗期间没有观察到任何严重的不良事件.
结论:
- 这一案例突显了类风湿性关节炎和抗SRPIMNM的罕见并发现象.
- 联合利图西马布和环胺治疗对于严重的抗SRPIMNM可能是有效和安全的.
- 需要进一步研究IMNM与结缔组织疾病之间的关联.
相关概念视频
01:23Rheumatic Heart Disease I: Introduction
1.0K
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
01:22Myasthenia Gravis ll: Pathophysiology
53
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53